1. Home
  2. PFX vs ELUT Comparison

PFX vs ELUT Comparison

Compare PFX & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFX
  • ELUT
  • Stock Information
  • Founded
  • PFX 2010
  • ELUT 2015
  • Country
  • PFX United States
  • ELUT United States
  • Employees
  • PFX N/A
  • ELUT N/A
  • Industry
  • PFX Finance: Consumer Services
  • ELUT Medical Specialities
  • Sector
  • PFX Finance
  • ELUT Health Care
  • Exchange
  • PFX Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • PFX 101.2M
  • ELUT 94.0M
  • IPO Year
  • PFX N/A
  • ELUT 2020
  • Fundamental
  • Price
  • PFX $49.25
  • ELUT $1.98
  • Analyst Decision
  • PFX
  • ELUT Strong Buy
  • Analyst Count
  • PFX 0
  • ELUT 2
  • Target Price
  • PFX N/A
  • ELUT $9.00
  • AVG Volume (30 Days)
  • PFX 749.0
  • ELUT 40.2K
  • Earning Date
  • PFX 05-06-2025
  • ELUT 05-08-2025
  • Dividend Yield
  • PFX 5.56%
  • ELUT N/A
  • EPS Growth
  • PFX N/A
  • ELUT N/A
  • EPS
  • PFX 5.09
  • ELUT N/A
  • Revenue
  • PFX $24,036,577.00
  • ELUT $24,375,000.00
  • Revenue This Year
  • PFX $16.80
  • ELUT $39.35
  • Revenue Next Year
  • PFX $0.74
  • ELUT $61.26
  • P/E Ratio
  • PFX $9.68
  • ELUT N/A
  • Revenue Growth
  • PFX 15.02
  • ELUT N/A
  • 52 Week Low
  • PFX $43.53
  • ELUT $1.79
  • 52 Week High
  • PFX $57.40
  • ELUT $5.24
  • Technical
  • Relative Strength Index (RSI)
  • PFX 36.35
  • ELUT 38.63
  • Support Level
  • PFX $48.99
  • ELUT $1.79
  • Resistance Level
  • PFX $51.08
  • ELUT $2.44
  • Average True Range (ATR)
  • PFX 0.27
  • ELUT 0.21
  • MACD
  • PFX -0.03
  • ELUT -0.01
  • Stochastic Oscillator
  • PFX 54.59
  • ELUT 28.46

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: